🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Detection

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection NCT06970288n/a1 site📍 Cairo Ain Shams University Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy NCT06282796n/a5 sites📍 Fuzhou📍 Dalian📍 Dalian First Hospital of China Medical University · Tests: Echocardiography ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health NCT07505797n/a2 sites📍 Sacramento📍 Cypress iSono Health, Inc. · Tests: ATUSA 3D Automated Breast Ultrasound System A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection NCT06291896NA10 sites📍 Genova📍 Foligno📍 Trieste Umbria Bioengineering Technologies · Tests: MammoWave A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection NCT05300464NA4 sites📍 Genova📍 Foligno📍 Trieste Umbria Bioengineering Technologies · Tests: Clinical investigation medical device class IIa marked CE Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients NCT07524829NA1 site📍 Asti Azienda Sanitaria Locale di Asti · Tests: Structured Telenursing Follow-up, Standard Nursing Care cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites📍 Duarte📍 Miami📍 Gainesville Adela, Inc Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer NCT07003009NA1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: Malign Lymph Node Washout, Benign Lymph Node Washout Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery NCT06977698n/a1 site📍 Nottingham University of Nottingham · Tests: OCT-Raman, AF-Raman Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer NCT04065321n/a2 sites📍 Shenyang📍 Shenyang Shengjing Hospital · Tests: PET-CT examination, Peripheral blood detection Avera Cancer Sequencing and Analytics Protocol (ASAP) NCT05142033n/a6 sites📍 Marshall📍 Aberdeen📍 Mitchell Avera McKennan Hospital & University Health Center Predicting Cancer Risk With Digital and Molecular Markers NCT06962670NA1 site📍 Please Refer to Project Homepage For Details (see Link Below) University of Erlangen-Nürnberg Medical School · Tests: Biomaterial collection, BayPass mobile application Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer NCT07146295NA7 sites📍 Alkmaar📍 Hengelo📍 Hoofddorp Isabelle Henskens · Tests: Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia NCT07741435n/a1 site📍 Bogotá Centro de Tratamiento e Investigación sobre Cáncer, Luis Ca… · Tests: Methylscape DNA methylation assay Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial NCT06636370NA1 site📍 Utrecht C.H. van Gils · Tests: Contrast-enhanced mammography (CEM), Abbreviated MRI (AB-MRI) Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study) NCT07362485NA2 sites📍 Zwolle📍 Utrecht Isabelle Henskens · Tests: Indocyanine green (ICG)-fluorescence guided sentinel lymph node biopsy fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases NCT06328465NA1 site📍 Milan European Institute of Oncology · Tests: Diffusion whole body MRI Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study NCT03408353n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Mammography, Questionnaire Administration Post-market Safety Study of LUMISIGHT NCT07572162n/a2 sites📍 Mobile📍 Palo Alto Lumicell, Inc. UCF MammoChat: Image Repository NCT07214883n/a1 site📍 Orlando University of Central Florida · Tests: No Interventions Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device NCT06807502NA1 site📍 Neuilly-sur-Seine ScreenCell · Tests: The DM/DIV ScreenCell is the experimental product studied during this research Multicenter Cardiac Decision Impact Study in People With Breast Cancer NCT07703033NA5 sites📍 Copenhagen📍 München📍 Amsterdam UMC Utrecht · Tests: Measuring coronary artery calcifications (Agatston score) using routine radiotherapy planning CT scans and communicatin… Population Based Germline Testing for Early Detection and Prevention of Cancer NCT07498829NA1 site📍 London Queen Mary University of London · Tests: Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) a… Characterization of Extracellular Vesicles in Breast Cancer Patients NCT05798338n/a1 site📍 Pavia Istituti Clinici Scientifici Maugeri SpA · Tests: Blood sample Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression NCT06938373n/a1 site📍 Changsha Xiangya Hospital of Central South University Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya NCT07764796NA1 site📍 Atlanta Emory University · Tests: Best Practice, Discussion, Interview - Stakeholder, Interview - Key Informant, Interview - Ancillary studies Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer NCT06876610n/a1 site📍 Beijing Geneplus-Beijing Co. Ltd. Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device NCT07407153NA1 site📍 Jakarta International Agency for Research on Cancer · Tests: Portable ultrasound device B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. NCT07236177EARLY Phase 11 site📍 Poitiers Poitiers University Hospital · Tests: blood plasma sample, blood sampling Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring NCT04799535n/a1 site📍 Rochester Mayo Clinic · Tests: Ultrasound
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy